Biosynthesis of nodulisporic acid A: precursor studies.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 12059229)

Published in J Am Chem Soc on June 19, 2002

Authors

Kevin M Byrne1, Scott K Smith, John G Ondeyka

Author Affiliations

1: Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065-0900, USA. kevin_byrne@merck.com

Articles by these authors

Isolation, structure, and absolute stereochemistry of platensimycin, a broad spectrum antibiotic discovered using an antisense differential sensitivity strategy. J Am Chem Soc (2006) 1.87

Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus. Chem Biol (2011) 1.80

Discovery of FabH/FabF inhibitors from natural products. Antimicrob Agents Chemother (2006) 1.51

Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc Natl Acad Sci U S A (2006) 1.44

Evaluation of smallpox vaccines using variola neutralization. J Gen Virol (2009) 1.21

Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges. Vaccine (2007) 1.21

Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model. J Virol (2007) 1.19

Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease. Virology (2010) 1.12

Structure and semisynthesis of platensimide A, produced by Streptomyces platensis. Org Lett (2008) 1.07

Nodulisporic acids D-F: structure, biological activities, and biogenetic relationships. J Nat Prod (2004) 1.06

Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases. J Virol (2010) 1.02

Antisense-guided isolation and structure elucidation of pannomycin, a substituted cis-decalin from Geomyces pannorum. J Nat Prod (2009) 0.97

Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa. J Nat Prod (2009) 0.96

Smallpox virus plaque phenotypes: genetic, geographical and case fatality relationships. J Gen Virol (2009) 0.94

Isolation and structure of antagonists of chemokine receptor (CCR5). J Nat Prod (2004) 0.93

Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis (2012) 0.93

Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005. Emerg Infect Dis (2013) 0.92

Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. J Am Chem Soc (2008) 0.91

Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. J Nat Prod (2005) 0.89

Isolation, enzyme-bound structure and antibacterial activity of platencin A1 from Streptomyces platensis. Bioorg Med Chem Lett (2009) 0.89

Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. Clin Infect Dis (2009) 0.88

Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines. Clin Vaccine Immunol (2012) 0.88

Discovery of okilactomycin and congeners from Streptomyces scabrisporus by antisense differential sensitivity assay targeting ribosomal protein S4. J Antibiot (Tokyo) (2009) 0.87

Novel sesquiterpenoids from the fermentation of Xylaria persicaria are selective ligands for the NPY Y5 receptor. J Org Chem (2002) 0.86

Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists. J Antibiot (Tokyo) (2005) 0.83

Highly substituted terphenyls as inhibitors of parasite cGMP-dependent protein kinase activity. J Nat Prod (2006) 0.83

Tenellones A and B from a Diaporthe sp.: two highly substituted benzophenone inhibitors of parasite cGMP-dependent protein kinase activity. J Nat Prod (2005) 0.82

Investigation of the first laboratory-acquired human cowpox virus infection in the United States. J Infect Dis (2012) 0.81

Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis. PLoS One (2010) 0.80

Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities. Bioorg Med Chem Lett (2012) 0.80

Guttiferone I, a new prenylated benzophenone from Garcinia humilis as a liver X receptor ligand. J Nat Prod (2005) 0.78

Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy. J Nat Prod (2008) 0.78

Vaccinia virus infections in martial arts gym, Maryland, USA, 2008. Emerg Infect Dis (2011) 0.78

Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy. Bioorg Med Chem (2008) 0.78

Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters. Bioorg Med Chem Lett (2005) 0.78

The pox in the North American backyard: Volepox virus pathogenesis in California mice (Peromyscus californicus). PLoS One (2012) 0.78

Isolation and structure elucidation of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa. J Antibiot (Tokyo) (2007) 0.76

Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity. Bioorg Med Chem Lett (2005) 0.76

Integracides: tetracyclic triterpenoid inhibitors of HIV-1 integrase produced by Fusarium sp. Bioorg Med Chem (2003) 0.75

Discovery, isolation, and structure elucidation of dretamycin. J Nat Prod (2014) 0.75

Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products. J Nat Prod (2003) 0.75

Orthopoxvirus variola infection of Cynomys ludovicianus (North American black tailed prairie dog). Virology (2013) 0.75

Coniothyrione: anatomy of a structure revision. Magn Reson Chem (2013) 0.75

Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease. Biochem Biophys Res Commun (2004) 0.75